drugset / Trial / NCT07502001
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the Influence of HDM1005 on gastric emptying and drug-drug interaction of HDM1005 and metformin, atorvastatin, warfarin, and digoxin in overweight/obese adult subjects.
Timeline
- Start
- 2026-04-08
- Primary completion
- 2026-12-01
- Completion
- 2027-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | — | Oral |
| Subject | Atorvastatin | Small molecule | — | Oral |
| Subject | Digoxin | Other / unclassified | — | Oral |
| Subject | HDM1005 | Unknown | — | Subcutaneous |
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Warfarin | Small molecule | — | Oral |